Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10
Autolus Therapeutics plc (NASDAQ:AUTL) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. Analyst Gil Blum from Needham reiterated a Buy rating on Autolus Therapeutics plc (NASDAQ:AUTL) on June 12, keeping the price target at $10.00.
The analyst cited the promising results of the FELIX study for obe-cel in patients with relapsed/refractory acute lymphoblastic leukemia (ALL) as one of the factors supporting the optimistic rating, stating that the updated analysis highlights a notable number of patients in remission with no need for further therapy. This is a positive indicator, according to the analyst, especially in comparison to other treatments such as Tecartus.
A laboratory technician carefully studying a microscope with a biopharmaceutical product inside.
While the analyst acknowledged that 38% of responders were still in remission with a median follow-up of 33 months, a slight drop from the 40% reported at 21.5 months, he stated that the results are still impressive. He also cited other promising factors, including the overall survival and event-free survival rates, as well as the absence of new safety concerns.
According to Blum, these factors suggest a positive reception from physicians and the potential for higher commercial adoption of obe-cel, supporting the optimistic outlook for Autolus Therapeutics plc (NASDAQ:AUTL).
Autolus Therapeutics (NASDAQ:AUTL) is a clinical-stage biopharmaceutical company based in the United Kingdom. It develops programmed T cell therapies for treating autoimmune diseases and cancer, with a focus on chimeric antigen receptor (CAR) T cell therapy.
The company engineers controlled, targeted, and highly active T cell therapy product candidates designed to recognize target cells, break their defense mechanisms down, and eliminate them. It is doing so using a portfolio of proprietary and modular T-cell programming technologies.
While we acknowledge the potential of AUTL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
an hour ago
- Washington Post
Spain's leader sticks by decision to break with NATO on spending despite Trump tariff threats
MADRID — Spanish Prime Minister Pedro Sánchez walked away from this week's NATO summit with an opt-out from spending more on defense. He also left with fresh threats of tariffs from U.S. President Donald Trump. On Thursday, the progressive Spanish leader stuck by his decision to break with NATO allies and responded to Trump's comments by pointing out that the European Commission — and not Spain — was who decided the bloc's trade policy. 'What is clear is that trade policy is a policy directed from here, from Brussels,' Sánchez said. 'Spain is an open country. It is a country that is friendly to its friends, and we consider the United States a friend of Spain.' At the military alliance's summit Wednesday, members agreed to raise their defense spending to 5% of GDP. But Sánchez secured a last-minute exemption, saying that Spain will only spend up to 2.1%, which he called 'sufficient and realistic.' Trump criticized Spain after the summit, saying the country wanted 'a little bit of a free ride,' and that it would 'have to pay it back to us on trade' through higher tariffs. How Sánchez's gamble could play out was up for debate on Thursday. 'It is not always easy to interpret exactly what Mr. Trump means,' Belgian Prime Minister Bart De Wever told reporters at an EU summit. 'How he wants to impose import tariffs on Spain separately is a mystery to everyone. Could this perhaps concern specific products from Spain? We will have to wait and see.' Spain's move on the international stage comes at a complex moment for Sánchez at home as corruption cases involving his inner circle have ensnared his Socialist party and resulted in louder calls — even from some leftwing allies — to announce early elections. So far, Sánchez has refused. 'To Trump's theatre, Sánchez responds with something similar,' said Montserrat Nebrera, political analyst and professor of constitutional law at the International University of Catalonia. 'Domestic problems are piling up, and this resistance to meeting the arbitrary 5% target also seeks to wink at his partners most critical of defense spending.' Spain was NATO's lowest spender last year, according to the alliance's estimates, spending around 1.28% of its GDP on defense expenditure. In April, Sánchez announced that the country would reach 2% this year, for which he was criticized by some leftwing allies. On Thursday, Antonio Garamendi, president of the Spanish Confederation of Business Organizations, criticized Sánchez for the spending opt-out. 'We have to stick with with our allies and not going along with the other Europeans is an error, and even more so if that increases the chance we will be punished,' Garamendi said. While Spain is under the umbrella of the European Union, which negotiates trade deals on behalf of all 27 member countries, it could still be targeted by tariffs that hit its most vulnerable industries, Garamendi said. He specifically pointed to Spanish steel, cars and olive oil sectors. 'There are industries that can be impacted, and that has to concern us,' he added. ___ Wilson reported from Barcelona. AP journalist Lorne Cook contributed from Brussels.
Bloomberg
an hour ago
- Bloomberg
Starmer Swings From Defiance to Deal-Making to Save Welfare Bill
Keir Starmer has pivoted to deal-making mode in a bid to stave off a damaging defeat on welfare cuts that are key to his chancellor's efforts to balance the UK books. When the prime minister first learned that over one hundred of his own Members of Parliament supported a plan to kill his government's bill implementing the changes to disability benefits, he was defiant, according to people familiar with the matter, who spoke anonymously about discussions that took place behind close doors.
Bloomberg
an hour ago
- Bloomberg
NATO's New Defense Spending Target Is a Big, Beautiful Number
NATO wrapped up two days of meetings in the Hague yesterday, with members of the security pact agreeing to one of President Donald Trump's longtime demands. Bloomberg TV's Oliver Crook examines the deal. Plus: America's top consumer-sentiment economist says the vibes are off. If this email was forwarded to you, click here to sign up.
